TASK vs. CPRX

Last updated Jun 4, 2026

TASK (TaskUs, Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. TASK operates in Information Technology Services (Technology), while CPRX operates in Biotechnology (Healthcare). Over the past 3 years, TASK returned 6.63%/yr vs 39.39%/yr for CPRX. At a 0.28 correlation, their price movements are largely independent.

Performance

TASK vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TaskUs, Inc. (TASK) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TASK achieves a 18.57% return, which is significantly lower than CPRX's 34.02% return.

TASK

• 1D: -9.43%
• 1M: -8.58%
• YTD: 18.57%
• 6M: 15.92%
• 1Y: -16.39%
• 3Y*: 6.63%
• 5Y*: —
• 10Y*: —

CPRX

• 1D: 0.03%
• 1M: 8.09%
• YTD: 34.02%
• 6M: 35.41%
• 1Y: 25.57%
• 3Y*: 39.39%
• 5Y*: 41.68%
• 10Y*: 48.24%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TASK vs. CPRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
TASK TaskUs, Inc.	18.57%	-30.40%	29.61%	-22.66%	-68.68%	73.56%
CPRX Catalyst Pharmaceuticals, Inc.	34.02%	11.84%	24.15%	-9.62%	174.74%	17.94%

Correlation

The correlation between TASK and CPRX is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (All Time) Calculated using the full available price history since Jun 14, 2021	0.28

Over the past year, the correlation between TASK and CPRX has dropped to 0.06 - well below their long-term average of 0.28, suggesting their price drivers have been diverging.

Fundamentals

Market Cap TASK : $545.53M CPRX : $3.97B
EPS TASK : $1.14 CPRX : $1.74
PE Ratio TASK : 5.16 CPRX : 17.98
PEG Ratio TASK : 0.13 CPRX : 0.32
PS Ratio TASK : 0.60 CPRX : 6.67
PB Ratio TASK : 1.98 CPRX : 3.92
Total Revenue (TTM) TASK : $905.76M CPRX : $596.96M
Gross Profit (TTM) TASK : $139.75M CPRX : $378.23M
EBITDA (TTM) TASK : $214.94M CPRX : $313.50M

Return for Risk

TASK vs. CPRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TASK

TASK Risk / Return Rank: 31
TASK Sharpe Ratio Rank: 31
TASK Sortino Ratio Rank: 32
TASK Omega Ratio Rank: 33
TASK Calmar Ratio Rank: 29
TASK Martin Ratio Rank: 28

CPRX

CPRX Risk / Return Rank: 60
CPRX Sharpe Ratio Rank: 65
CPRX Sortino Ratio Rank: 59
CPRX Omega Ratio Rank: 59
CPRX Calmar Ratio Rank: 60
CPRX Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TASK vs. CPRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TaskUs, Inc. (TASK) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TASK	CPRX	Difference
Sharpe ratio Return per unit of total volatility	-0.22	0.76	-0.99
Sortino ratio Return per unit of downside risk	0.11	1.25	-1.14
Omega ratio Gain probability vs. loss probability	1.02	1.16	-0.15
Calmar ratio Return relative to maximum drawdown	-0.35	0.94	-1.30
Martin ratio Return relative to average drawdown	-0.67	1.71	-2.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TASK vs. CPRX - Sharpe Ratio Comparison

The current TASK Sharpe Ratio is -0.22, which is lower than the CPRX Sharpe Ratio of 0.76. The chart below compares the historical Sharpe Ratios of TASK and CPRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TASK	CPRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.22	0.76	-0.99
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.88	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.80	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.21	0.09	-0.29

Drawdowns

TASK vs. CPRX - Drawdown Comparison

The maximum TASK drawdown since its inception was -90.21%, roughly equal to the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for TASK and CPRX.

Drawdown Indicators

	TASK	CPRX	Difference
Max Drawdown Largest peak-to-trough decline	-90.21%	-94.25%	+4.04%
Max Drawdown (1Y) Largest decline over 1 year	-46.46%	-27.29%	-19.17%
Max Drawdown (3Y) Largest decline over 3 years	-48.52%	-27.29%	-21.23%
Max Drawdown (5Y) Largest decline over 5 years	—	-45.37%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-64.87%	—
Current Drawdown Current decline from peak	-83.26%	-0.16%	-83.10%
Average Drawdown Average peak-to-trough decline	-73.79%	-52.05%	-21.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.47%	14.95%	+9.52%

Volatility

TASK vs. CPRX - Volatility Comparison

TaskUs, Inc. (TASK) has a higher volatility of 18.50% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 6.81%. This indicates that TASK's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TASK	CPRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.50%	6.81%	+11.69%
Volatility (6M) Calculated over the trailing 6-month period	58.25%	23.58%	+34.67%
Volatility (1Y) Calculated over the trailing 1-year period	73.41%	33.60%	+39.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.60%	47.86%	+24.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.60%	60.61%	+11.99%

Dividends

TASK vs. CPRX - Dividend Comparison

TASK's dividend yield for the trailing twelve months is around 124.57%, while CPRX has not paid dividends to shareholders.

Position	TTM
CPRX Catalyst Pharmaceuticals, Inc.	0.00%
TASK TaskUs, Inc.	124.57%

Financials

Frequently Asked Questions

Can I hold both TASK and CPRX in my portfolio?

TASK and CPRX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TASK or CPRX?

TASK has higher volatility (18.50%) compared to CPRX (6.81%). In terms of maximum drawdown, TASK dropped -90.21% vs CPRX's -94.25%.

Which has better risk-adjusted returns?

CPRX currently has the higher Sharpe Ratio (0.76 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.